Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, Garcia-Delpech S.
Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
Am J Ophthalmol. 2007 Jul;144(1):122-4.

Ahn, J. K. and Y. G. Park .
Human leukocyte antigen B27 and B51 double-positive Behcet uveitis.
Arch Ophthalmol 125(10): 1375-80.

Ardoin, S. Kredich, D. Rabinovich, E. Schanberg, L. E. Jaffe, G. J.
Infliximab to Treat Chronic Noninfectious Uveitis in Children: Retrospective Case Series with Long-term Follow-up.
Am J Ophthalmol 144(6): 844-849.

Birnbaum, A.D.T., H. H. Schultz, K. L. Farber, M. D. Gao, W. Lin, P. Oh, F. Goldstein, D. A.,
Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program.
Am J Ophthalmol, 2007. 144(3): p. 424-428.

Bourla DH, Sarraf D, Schwartz SD.
Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Am J Ophthalmol. 2007 Jul; 144(1):126-8.

Calfa CJ, Lossos IS, Ruiz P, Davis JL.
Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia.
Am J Ophthalmol. 2007 Aug;144(2):326-9

Deeg, C.A., et al.
Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier.
Proteomics, 2007. dans vasculaire ou recherché?

Dille, B.
Toxicity of intraocular gentamicin.
Arch Ophthalmol, 2007. 125(10): p. 1442; author reply 1442-3.

Fan H, Lee VY, Liu DT, Li CL, Lam DS.
Re: bilateral macular lesions in a 10-year-old girl.
Am J Ophthalmol. 2007 Aug; 144(2):334; author reply 334-5

Feltgen, N., et al.
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Ophthalmology, 2007. 114(4): p. 716-23.

Ferrara, D.C., H. Koizumi, and R.F. Spaide
Early Bevacizumab Treatment of Central Retinal Vein Occlusion.
Am J Ophthalmol, 2007. 144 (6) : 864-71

Goldstein, D. A. Godfrey, D. G Hall, A. Callanan, D. G. Jaffe, G. J. Pearson, P. A. Usner, D. W. Comstock, T. L.
Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants.
Arch Ophthalmol, 2007 ; 125 (11) : 1478-85

Gutfleisch, M., et al.
Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.
Br J Ophthalmol, 2007. 91(3): p. 345-8.

Hasan, S.A. and M.W. Stewart,
Cystoid macular edema following photorefractive keratectomy complicated by presumptive infectious keratitis.
J Cataract Refract Surg, 2007. 33(2): p. 348-9.

Hauck, S.M., et al.
Retinal Mueller Glial Cells Trigger the Hallmark Inflammatory Process in Autoimmune Uveitis.
J Proteome Res, 2007.

Heinz, C. and A. Heiligenhaus,
Improvement of noninfectious uveitis with fumaric Acid esters: results of a pilot study.
Arch Ophthalmol, 2007. 125(4): p. 569-71.

Jabs, D.A., et al.
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Ophthalmology, 2007. 114(4): p. 780-6.

Jabs, D.A., et al.,
Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
Ophthalmology, 2007. 114(4): p. 787-93.

Koizumi, H. Ferrara, D. C. Brue, C. Spaide, R. F
Central Retinal Vein Occlusion Case-Control Study.
Am J Ophthalmol 144(6): 858-863.

McIntosh RL, et al.
Interventions for branch retinal vein occlusion: an evidence-based systematic
review.
Ophthalmology. 2007 May;114(5):835-54.

Maia Junior OO, Bonanomi MT, Takahashi WY, Nascimento VP, Takahashi BS.
Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.
Am J Ophthalmol. 2007 Aug;144(2):296-9.

Matsumoto, Y., et al.,
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.
Retina, 2007. 27(4): p. 426-31.

Morrison, V.L., et al.
Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Ophthalmology, 2007. 114(2): p. 334-9.

Natkunarajah, M., S. Kaptoge, and C. Edelsten,
Risks of relapse in patients with acute anterior uveitis.
Br J Ophthalmol, 2007. 91(3): p. 330-4.

Pai SA, et al.
Clinical, anatomic, and electrophysiologic evaluation following intravitreal
bevacizumab for macular edema in retinal vein occlusion.
Am J Ophthalmol. 2007 Apr;143(4):601-6.

Plskova, J.G., K. Forrester, J. V.
Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.
Am J Ophthalmol, 2007. 144(1): p. 55-61.

Radhakrishnan, S. Bala, E. Peachey, N. S. Lewis, H. Traboulsi, E. I.
Bilateral macular lesions in a 10-year-old girl
Am J Ophthalmol. 2007Jan;143(1):184-5.

Rizzolo, L.J.
Development and role of tight junctions in the retinal pigment epithelium.
Int Rev Cytol, 2007. 258: p. 195-234.

Rothova, A.
The riddle of fuchs heterochromic uveitis.
Am J Ophthalmol, 2007. 144(3): p. 447-8.

Saurenmann, R.K., et al.
Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Arthritis Rheum, 2007. 56(2): p. 647-57

Schaal KB, et al.
Bevacizumab for the treatment of macular edema secondary to retinal vein
occlusion
Ophthalmologe. 2007 Apr;104(4):285-9.

Sepulcre, J.M.-F., et al.
Diagnostic accuracy of retinal abnormalities in predicting disease activity in Multiple Sclerosis.
Neurology, 2007. 68(18): p. 1488-94.

Seth, R.K.S., K. M. Adelman, R. A.,
Choroidal neovascularization associated with west nile virus chorioretinitis.
Semin Ophthalmol, 2007. 22(2): p. 81-4.

Schuster, A., et al.
The phenotype of early-onset retinal degeneration in persons with RDH12 mutations.
Invest Ophthalmol Vis Sci, 2007. 48(4): p. 1824-31

Stifter, E.M., S. Prager, F.Georgopoulos, M. Polak, K. Hirn, C. Schmidt-Erfurth, U.
Intravitreal Bevacizumab Therapy for Neovascular Age-related Macular Degeneration with Large Submacular Hemorrhage.
Am J Ophthalmol 144(6): 886-892.

Sugita, S. Shimizu, N. Kawaguchi, T. Akao, N. Morio, T. Mochizuki, M.
Identification of human herpes virus 6 in a patient with severe unilateral panuveitis.
Arch Ophthalmol, 2007. 125(10): p. 1426-7.

Taban M, Singh RP, Chung JY, Lowder CY, Perez VL, Kaiser PK.
Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Am J Ophthalmol. 2007 Jul;144(1):50-54.

Theodossiadis, P.G., N.N. Markomichelakis, and P.P. Sfikakis
Tumor necrosis factor antagonists :
Preliminary Evidence for an Emerging Approach in the
Treatment of Ocular Inflammation.
Retina, 2007. 27(4): p. 399-413.

Traill, A., et al.
Macular thickening in acute anterior uveitis.
Ophthalmology, 2007. 114(2): p. 402

Ufret-Vincenty, R.L., et al.
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Am J Ophthalmol, 2007. 143(2): p. 334-5.

Woreta, F., et al.
Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.
Am J Ophthalmol, 2007. 143(4): p. 647-5

Yamaguchi Y, Otani T, Kishi S.
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Am J Ophthalmol. 2007 Aug;144(2):260-5.

Yamamoto, T. Kamei, M. Kunavisarut, P Suzuki, M. Tano, Y.
Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
Graefes Arch Clin Exp Ophthalmol, 2007. oct 25